Kinase inhibitor phosphonate conjugates

Details for Australian Patent Application No. 2004308974 (hide)

Owner Gilead Sciences, Inc.

Inventors Watkins, Will

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004308974

PCT Pub. Number WO2005/063258

Priority 10/832,811 26.04.04 US; 60/531,932 22.12.03 US; PCT/ US2004/013062 26.04.04 US; 60/622,962 26.10.04 US

Filing date 22 December 2004

Wipo publication date 14 July 2005

International Classifications

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063258 Priority application(s): WO2005/063258

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308976-Zeaxanthin formulations with additional ocular-active nutriente, for protecting eye health and treating eye disorders

2004308973-Methods and dosage forms for increasing solubility of drug compositions for controlled delivery